Quick blood test could speed up early abortion care
NCT ID NCT07417787
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether a simple, rapid blood test can confirm that a very early medical abortion (under 6 weeks) has worked. Usually, women need to wait 7 days for a follow-up blood test. This study checks if the test can be done as early as 2-4 days after treatment. Researchers will also ask patients and staff about their experience with the test. The goal is to make follow-up faster and more accessible.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- point-of-care HCG blood test
- What this could lead to
- If successful, this could allow women to confirm abortion completion earlier and more conveniently, reducing clinic visits.
- What could go wrong
- This is a small, early-stage study focused on test accuracy, not a new treatment. The test may not be reliable enough to replace standard follow-up.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ABORTION EARLY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chalmers Sexual Health Clinic
RECRUITINGEdinburgh, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Karolinska Institutet
NOT_YET_RECRUITINGStockholm, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Gothenberg
NOT_YET_RECRUITINGGothenburg, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.